VNDA — VANDA PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  14 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in VANDA PHARMACEUTICALS INC (VNDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.04% (2025 Q2)
Avg. % of fund
0.01%
First filed
2019 Q4
Last filed
2025 Q4
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 349,300 +327,233 +1482.9% 0.02% $3.1M $8.82
2025 Q3 REDUCED 22,067 -14,933 -40.4% 0.00% $110K $4.99
2025 Q3 REDUCED 37,000 -147,486 -79.9% 0.00% $185K $4.99
2025 Q2 REDUCED 184,486 -515,514 -73.6% 0.01% $871K $4.72
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VNDA price (monthly, adj. close)

Other funds also holding VNDA

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 4.27% Krensavage Asset Management, LLC 3Y 7Y 3.68% Empire Financial Management Company, LLC 2.12% Monaco Asset Management SAM 3Y 0.3% Sassicaia Capital Advisers LLC 3Y 0.28% KOTLER KEVIN 0.21% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.11% STEMPOINT CAPITAL LP 0.09% Inscription Capital, LLC 3Y 0.06% AXQ CAPITAL, LP 3Y 0.05%
← Back to Caption Management, LLC Holdings